Quintiles named CRO of the year; Capsugel expands QC capabilities;

> Quintiles founder Dennis Gillings received the Scrip Intelligence Lifetime Achievement award, and his company was named CRO of the year at the 2012 Scrip Awards. Release

> In India, medical professionals are finding new opportunities--and more money--with CROs. Article

> As APIs get less and less soluble, Merck Millipore sees a market opening for its bioavailability solutions. News

> Icon ($ICLR) has launched a web-based portal that allows investigators to access study-specific clinical information and lab reports any time, from any place. More

> Pfizer ($PFE) is getting back to work on its failed online-only clinical trial program and could relaunch it as early as next year. Story

> Capsugel is investing more than $3 million in a new quality control lab, and the 9,600-square-foot facility will double its lab capacity and house analytic and microbial testing. Item


Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.